Serbia has begun negotiations on the production of a Russian vaccine against the Sputnik V coronavirus. This was reported on the official website of the government.
In particular, the Serbian Minister of Innovation Nenad Popovic, together with representatives of the Serbian Ministry of Health, visited the pharmaceutical company Generium in the Vladimir region, where the Russian vaccine is produced. During the visit, the parties signed a protocol specifying further steps to create a joint venture. Popovich admitted that the vaccine produced in the country will be supplied to other Balkan and southern European states.
The possibility of producing Sputnik V is also being considered in other European countries. So, German Chancellor Angela Merkel previously allowed the joint production and use of the Russian drug. According to her, a prerequisite for this is the approval of the European regulator. On January 20, it became known that Moscow had submitted an application to the European Medicines Agency (EMA) to register Sputnik V in the European Union.
Hungary was the first in the European Union to approve the Sputnik V vaccine. The Russian drug is also registered in Belarus, Serbia, Argentina, Bolivia, Algeria, UAE, Palestine, Venezuela, Paraguay and Turkmenistan.
